⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GPCR News
Structure Therapeutics Inc. American Depositary Shares
Form 8-K
sec.gov
GPCR
Structure Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
globenewswire.com
GPCR
Structure Therapeutics to Present Aleniglipron, Amylin and Combination Data at the American Diabetes Association 86th Scientific Sessions
globenewswire.com
GPCR
Form 8-K
sec.gov
GPCR
Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel
globenewswire.com
GPCR
Form 8-K
sec.gov
GPCR
Structure Therapeutics Reports Positive Topline Data from Phase 2 ACCESS II Trial with Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron
globenewswire.com
GPCR
Form 8-K
sec.gov
GPCR
Structure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights
globenewswire.com
GPCR
PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race
globenewswire.com
MDBH
LLY
NVO
PFE
AZN
GILD
GPCR